Use caution Drug recall · FDA · Published July 13, 2026

Rising Pharma Recalls Cyproheptadine Syrup Due to Crystallization

Rising Pharma recalls Cyproheptadine Hydrochloride Syrup (2mg/5 mL) due to precipitate formation. Check your bottle's lot number and expiration date for affected batches.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0724-2026Drug Rising Pharma ›

Use caution until it’s fixed

Presence of Precipitate: medication was crystallizing and particles floating in the bottle

✎ GovInfoNow plain-language explainer

Rising Pharma Holding, Inc. is recalling Cyproheptadine Hydrochloride Syrup because medication particles are crystallizing and floating in the bottle. This issue affects specific lots distributed nationwide in the U.S. The recall covers 74,208 units of this prescription-only medication. Read more at govinfonow.com/recall/92433-rising-pharma-recalls-cyproheptadine-syrup-due-to-crystallization.

Source Summary by GovInfoNow · govinfonow.com/recall/92433-rising-pharma-recalls-cyproheptadine-syrup-due-to-crystallization · Updated October 9, 2026 · FDA enforcement record: FDA #D-0724-2026

Cite this page

“Rising Pharma Recalls Cyproheptadine Syrup Due to Crystallization.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/92433-rising-pharma-recalls-cyproheptadine-syrup-due-to-crystallization. Based on FDA recall #D-0724-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0724-2026%22&limit=1).

The FDA announced on July 13, 2026, that Rising Pharma Holding, Inc. is recalling Cyproheptadine Hydrochloride Syrup due to the presence of precipitate. The agency said the medication was crystallizing with particles floating in the bottle.

How to tell if you have it

Brand: Rising Pharma
Product: Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT)
NDC: 64980-504-48
Lots: CR2518 (Exp. 11/2027), CR2601 (Exp. 12/2027), CR2602, CR2603 (Exp. 01/2028), CR2604, CR2605 (Exp. 02/2028)
Units: 74,208

The hazard

The FDA said the hazard is the presence of precipitate, where medication was crystallizing and particles were floating in the bottle.

Context

GovInfoNow's records show Rising Pharma Holding, Inc. has had eight other recalls since December 29, 2023, including issues with Temozolomide capsules on March 3, 2026, Carbidopa Levodopa Entacapone tablets on October 7, 2025, and Duloxetine capsules on March 5, 2025. Other recent recalls of similar products include Par Health Buprenorphine Injection Recall (June 12, 2026), Heritage Pharma Recalls Clindamycin Oral Solution (July 30, 2026), and American Regent ACETYLCYSTEINE Solution Recall (July 24, 2026).

How to tell if you have this one

Check your bottle for 'Rising' brand Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, in a 473 mL (one pint) container. Look for NDC 64980-504-48 and verify if the lot number is CR2518, CR2601, CR2602, CR2603, CR2604, or CR2605 with expiration dates ranging from November 2027 to February 2028.

Brand
Rising Pharma
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Your Bottle
Verify if your bottle matches the recalled NDC and lot numbers listed in the record.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider to determine if you have an affected batch and what steps to take next.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 16 days after the firm started it.

Jul 13, 2026Firm started the recall
Jul 23, 2026FDA classified it Class II
Jul 29, 2026Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/92433-rising-pharma-recalls-cyproheptadine-syrup-due-to-crystallization">Rising Pharma Recalls Cyproheptadine Syrup Due to Crystallization (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0724-2026 (July 13, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0724-2026 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.